This study is currently not recruiting participants.

Open Label Use of Inhaled Gaseous Nitric Oxide (gNO) for a Single Adult with Non-Tuberculous Mycobacteria Infection

Study on Inhaled Nitric Oxide for Nontuberculous Mycobacteria (NTM)

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this protocol is to evaluate the use of inhaled nitric oxide in a single adult with NTM and review the efficacy and provide a safety signal as determined by change in bacterial sputum load, methemoglobin, and adverse events.

Detailed description of study

The purpose of this protocol is to evaluate the use of inhaled nitric oxide in a single adult with NTM and review the efficacy and provide a safety signal as determined by change in bacterial sputum load, methemoglobin, and adverse events.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-Tuberculous Mycobacteria Infection
  • Age: 100 years or below
  • Gender: All

This study investigates the use of inhaled nitric oxide for treating a condition known as NTM, which stands for nontuberculous mycobacteria. NTM is a type of bacterial infection that affects the lungs. The study aims to see how effective the treatment is by looking at changes in the amount of bacteria in the sputum, which is the mucus coughed up from the lungs.

Participants will undergo procedures to measure the levels of methemoglobin, a form of hemoglobin that can indicate how well the blood is carrying oxygen. The study will also monitor for any adverse events, which are any unwanted effects that may occur during the treatment.

  • Who can participate: The study is open to all adults with nontuberculous mycobacteria (NTM).
  • Study details: Participants will receive inhaled nitric oxide to evaluate its effects on NTM. The study will include monitoring of methemoglobin levels and any adverse events.
Updated on 19 Feb 2024. Study ID: 1711020205

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team